HealthcareServices

Global Multiomics Services Industry Trends and Market Forecast 2026–2030

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the multiomics services market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Multiomics Services Market between 2026 and 2030?

The multiomics services market has experienced substantial growth in its size over recent years. This market is projected to expand from $1.42 billion in 2025 to reach $1.71 billion in 2026, with a compound annual growth rate (CAGR) of 20.4%. Historically, factors contributing to this growth include a rise in genomics and proteomics research, increased funding for academic and clinical research, wider access to high-throughput sequencing technologies, enhanced collaboration between research institutions, and progress in bioinformatics tools.

The multiomics services market is poised for significant expansion in the next few years, with projections indicating a growth to $3.56 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 20.1%. This anticipated growth is primarily driven by the increasing adoption of precision medicine approaches, rising pharmaceutical investment in systems biology, the expansion of multiomics applications in drug discovery, the growing use of AI-based biological data interpretation, and an increasing demand for personalized therapeutic development. Key trends observed within this forecast period include the increasing adoption of integrated multiomics analysis platforms, a rising demand for single-cell multiomics services, the growing utilization of data-driven biological insights, the expansion of cloud-based omics data integration, and an enhanced focus on translational research applications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27355&type=smp

Which Drivers Are Expected To Impact The Multiomics Services Market During The Forecast Period?

The expanding embrace of personalized medicine is anticipated to fuel the growth of the multiomics services market going forward. Personalized medicine describes a medical framework that utilizes insights into a person’s genetic makeup and environmental lifestyle to customize treatments and healthcare solutions for their specific requirements. This increasing uptake of personalized medicine is attributable to individuals preferring health technologies that offer real-time monitoring and treatment plans tailored to their unique biological characteristics. Multiomics services contribute to advancing personalized medicine by integrating diverse biological data, such as genomics, transcriptomics, proteomics, and metabolomics, to provide a holistic understanding of an individual’s health profile, thereby enabling bespoke diagnosis, therapy, and disease prevention strategies. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, which was a notable increase from the 12 approved in 2022. Consequently, the rising adoption of personalized medicine is propelling the expansion of the multiomics services market.

Which Segments Are Driving Activity In The Multiomics Services Market?

The multiomics services market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Application: Biomarker Discovery, Drug Discovery And Development, Synthetic Biology, Other Applications

3) By End Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics Services, Single-Cell Transcriptomics Services, Single-Cell Proteomics Services, Single-Cell Epigenomics Services

2) By Bulk Multiomics: Genomics And Transcriptomics Integration Services, Genomics And Proteomics Integration Services, Transcriptomics And Proteomics Integration Services, Epigenomics And Transcriptomics Integration Services

What Industry Trends Are Transforming The Multiomics Services Market?

Major companies within the multiomics services market are focusing on creating innovative methods, such as 3D genome mapping, to improve the understanding of gene regulation, disease mechanisms, and personalized treatment approaches. 3D genome mapping describes the process of identifying the three-dimensional spatial arrangement of the genome within a cell’s nucleus. For instance, in January 2025, Enhanc3D Genomics, a UK-based biotechnology company, introduced a set of 3D multi-omics solutions designed to accelerate and enhance the precision of drug discovery. These solutions offer distinct features like the integration of genome-wide regulatory interaction data with multi-omics profiles in a single assay, providing comprehensive insights into gene regulation. Their proprietary Promoter Capture Hi-C technology enables the accurate mapping of long-range interactions between regulatory elements and target genes, including those found in non-coding regions. The platform’s modular design, incorporating GenLinkConnect, GenLinkResponse, and GenLinkProfile, respectively facilitates SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling. Additionally, the GenLinkHub software offers an intuitive interface for 3D visualization, data management, and quality control, thereby enhancing researchers’ capability to interpret complex datasets and expedite drug discovery.

Which Key Market Players Are Investing In Expansion And Innovation Within The Multiomics Services Market?

Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., Clinical Microbiomics A/S.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/multiomics-services-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Multiomics Services Market?

North America was the largest region in the multiomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Multiomics Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27355&type=smp

Browse Through More Reports Similar to the Global Multiomics Services Market 2026, By The Business Research Company

Pet Diabetes Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Disability Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/disability-insurance-global-market-report

Pet Healthcare Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-healthcare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795